Clinical trials
Glaucoma, Open-Angle trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Terminated | 14 |
| Recruiting | 11 |
| Unknown status | 6 |
| Active, not recruiting | 5 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wills Eye | 7 |
| Alcon Research | 5 |
| Glaukos Corporation | 5 |
| Sight Sciences, Inc. | 4 |
| Ivantis, Inc. | 3 |
| Sensimed AG | 3 |
| Stanford University | 3 |
| University of Colorado, Denver | 3 |
| Elios Vision, Inc. | 2 |
| Johns Hopkins University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma, Open-Angle | 82 |
| Glaucoma | 28 |
| Ocular Hypertension | 10 |
| Cataract | 6 |
| Exfoliation Syndrome | 4 |
| Choroidal Effusions | 2 |
| Glaucoma, Neovascular | 2 |
| Anxiety Disorders | 1 |
| Dry Eye Syndromes | 1 |
| Glaucoma, Angle-Closure | 1 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.